The Hemophilia Center of Western Pennsylvania is a state and federally-funded 501(c)3 charitable organization that provides comprehensive medical care to the residents of Western Pennsylvania with hemophilia and other bleeding and clotting disorders. The Center was among the first to be included in the federally funded national network of Hemophilia Treatment Centers established in 1975.

HCWP provides medical care in a comprehensive care model that includes:

  • Annual medical evaluations
  • Coagulation evaluation, including diagnosis, clinical and therapeutic monitoring & treatment
  • Clotting factor infusions
  • Education and training for home self-infusion treatment
  • Laboratory testing, including hematology, chemistry, serologic, and virologic testing
  • On-site physical therapy evaluation and management
  • Genetic counseling
  • Psychosocial services
  • Access to medical treatment trials, including gene therapy
  • Assessment, education, and training of inhibitor patients regarding immune tolerance treatment
  • Ongoing surveillance for transmissible viral infection, including HIV, hepatitis A, B, C
  • Education to patients, families, and providers
  • Medical consultation to health care providers, surgeons, and patients locally and across the country

As a federally funded comprehensive hemophilia treatment center, HCWP qualifies and participates in the federal 340B Drug Pricing Program by maintaining a clotting factor program. HCWP’s factor program was established in 2001 and has allowed the Center to improve its patient services and programs through its 340B resources.

Since HCWP’s participation in the 340B factor program, the Center has expanded its patient services including: adding physical therapy and genetic counseling services, adding additional adult and pediatric physicians, adding additional clinical and research nurses and providing support for three annual patient outreach clinics. Additionally, the factor program has allowed the Center to support the educational, insurance and research needs of the bleeding disorder community through entities such as the local chapter of the National Hemophilia Foundation, Patient Services Inc., The American Thrombosis and Hemostasis Network, The Foundation for Women & Girls with Blood Disorders, The World Federation of Hemophilia, and the University of Pittsburgh’s Vascular Medicine Institute.